You have 9 free searches left this month | for more free features.

rigosertib

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Rigosertib
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 28, 2023

NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Feb 8, 2022

Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)

Terminated
  • Leukemia
  • +3 more
  • Rigosertib
  • Questionnaire
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 5, 2020

Myelodysplastic Syndrome Trial in New York (rigosertib)

Withdrawn
  • Myelodysplastic Syndrome
  • rigosertib
  • New York, New York
    Columbia University Medical Center
Jun 29, 2020

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • rigosertib
  • +2 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

Healthy Trial in Madison (rigosertib)

Completed
  • Healthy
  • rigosertib
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
Jun 22, 2017

Myelodysplastic Syndrome, MDS, Trisomy 8 Trial in United States (rigosertib)

Completed
  • Myelodysplastic Syndrome
  • +2 more
  • rigosertib
  • Scottsdale, Arizona
  • +4 more
Jun 22, 2017

Solid Tumor Trial in Denver (rigosertib)

Completed
  • Solid Tumor
  • rigosertib
  • Denver, Colorado
    University of Colorado at Denver Health and Sciences
Jun 22, 2017

Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Myeloproliferative Disease Trial in Houston (rigosertib)

Completed
  • Acute Myelocytic Leukemia
  • +3 more
  • rigosertib
  • Houston, Texas
    University of Texas M. D. Anderson Cancer Center
Jun 22, 2017

Head and Neck Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma Trial in United States

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +6 more
  • rigosertib
  • Sacramento, California
  • +12 more
Jun 22, 2017